Lily Scollo, APN
Nurse Practitioner
1+
Years in Practice
About Lily Scollo
Lily Scollo, NP is a healthcare provider.
Specialty Definition
Definition to come...
2
Years Experience
1
States Licensed
Credentials & Board Certifications
Primary Specialty
Nurse PractitionerCredentials verified via NPI Registry (NPPES)
Education & Training
Medical School
Other
Class of 2024
Licenses & Practice States
Licensed in 1 state
| State | License | Classification | Primary |
|---|---|---|---|
| New Jersey | 26NJ15265600 | Nurse Practitioner |
Public Data Summary for Lily Scollo
In their first decade of practice, Lily Scollo represents the newer generation of nurse practitioner providers, APN, after earning their medical degree at Other in 2024. Their National Provider Identifier (NPI) is 1003620048, and the profile below combines data from CMS NPPES, Medicare billing records, the HHS OIG exclusion list, and — where available — CMS Open Payments, Medicare Utilization, and Part D prescriber summaries.
Transparency & Safety
Public records from CMS and OIG databases
Opioid Prescribing
This provider has no opioid prescriptions on file in Medicare Part D data.
Insurance & Accessibility
Reviews
Community reviews for Lily Scollo
--
0 reviews
Nurse Practitioner Providers Nearby
Same primary specialty near ZIP 07652
FAQ
Frequently asked questions about Lily Scollo
What does Lily Scollo specialize in?
Lily Scollo specializes in Nurse Practitioner.
Does Lily Scollo accept Medicare?
CMS records show that Lily Scollo accepts Medicare assignment. Call the practice directly to confirm Medicare acceptance for your specific plan.
What is Lily Scollo's NPI number?
Lily Scollo's National Provider Identifier (NPI) is 1003620048. This is the unique 10-digit number the Centers for Medicare & Medicaid Services assigns to every practicing US healthcare provider. You can verify this number directly at the NPPES NPI Registry.
How long has Lily Scollo been practicing?
Lily Scollo has approximately 1 year of practice experience, having graduated from Other in 2024.